scholarly journals Data in support of effect of blue LED irradiation in human lymphoma cells

Data in Brief ◽  
2016 ◽  
Vol 6 ◽  
pp. 630-633 ◽  
Author(s):  
Phil-Sun Oh ◽  
Hyosook Hwang ◽  
Hwan-Seok Jeong ◽  
Jeongil Kwon ◽  
Hyun-Soo Kim ◽  
...  
2021 ◽  
Vol 23 (2) ◽  
pp. 774-779
Author(s):  
Pengfei Niu ◽  
Jingya Yang ◽  
Yong Yuan ◽  
Yongxin Zhang ◽  
Chenxing Zhou ◽  
...  

A redox-neutral decarboxylative radical–radical coupling reaction of heteroaryl methylamines with NHPI esters has been developed by employing a copper complex as a photocatalyst with blue LED irradiation.


APOPTOSIS ◽  
2006 ◽  
Vol 11 (11) ◽  
pp. 2031-2042 ◽  
Author(s):  
Ingegerd Eggen Furre ◽  
Michael T. N. Møller ◽  
Susan Shahzidi ◽  
Jahn M. Nesland ◽  
Qian Peng

2009 ◽  
Vol 28 (6) ◽  
pp. 545-551 ◽  
Author(s):  
Young-Ok Son ◽  
Yong-Suk Jang ◽  
Xianglin Shi ◽  
Jeong-Chae Lee

2020 ◽  
Author(s):  
Mingyu He ◽  
Guanghui Li ◽  
Xiaoqi He ◽  
Yang Wang ◽  
Hong Lei ◽  
...  

Abstract Phototherapies, including sunlight, infrared, ultraviolet, visible and laser, parts of which present high curative effect, small invasion, and negligible adverse reactions in cancer treatment. Here we aimed to explore the potential therapeutical effects of blue LED in hepatoma cell and decipher the underlying cellular/molecular mechanisms. We demonstrated that the irradiation of blue LED light in hepatoma cell could lead to cell proliferation reduction along with the cell apoptosis increase. Simultaneously, blue LED irradiation also markedly suppressed the migration and invasion ability of hepatoma cells. Sphere formation analysis further revealed the decreased stemness of hepatoma cell under the treatment of blue LED irradiation. In addition, blue LED irradiation significantly promoted the expression of γ-H2AX, a sensitive molecular marker of DNA damage. Collectively, we demonstrated that blue LED irradiation exhibited anti-tumor effects on liver cancer by inducing DNA damage, representing a potential approach for human hepatoma treatment.


Blood ◽  
1993 ◽  
Vol 82 (1) ◽  
pp. 262-267 ◽  
Author(s):  
R Stauder ◽  
S Hamader ◽  
B Fasching ◽  
G Kemmler ◽  
J Thaler ◽  
...  

The interaction of human lymphoma cells with high endothelial venules (HEVs) on sections of lymphatic tissues was studied in 44 cases of non- Hodgkin's lymphoma (NHL) with the in vitro HEV binding assay. The relative adherence ratio (RAR) of lymphoma cells to HEVs as related to that of reactive lymphocytes was 0.29 to 4.64 in 38 cases of B chronic lymphocytic leukemia (CLL), 1.15 and 1.54 in two cases of immunocytic NHL, 1.12 and 0.70 in two cases of centrocytic NHL, 1.98 in one case of a peripheral T-NHL, whereas plasma cell leukemia cells adhered very weakly (RAR 0.1). Among the patients suffering from CLL a pronounced HEV binding ability of tumor cells correlated significantly with the more unfavorable Binet stages B and C (median 1.32) as well as with a widespread lymphatic dissemination, which strongly indicates a hematogenous, HEV-mediated spread (median 1.34). In contrast, weak adherence to HEVs was associated with Binet stage A (median 0.85; P < .05) and with a lacking or only localized clinical involvement of lymph nodes (median 0.84; P < .01). Thus, specific HEV recognition processes even operate in lymphoid neoplasms and via this mechanism seem to influence the dissemination of tumors.


2019 ◽  
Vol 58 (47) ◽  
pp. 16700-16700
Author(s):  
Tristan Chidley ◽  
Islam Jameel ◽  
Shafa Rizwan ◽  
Philippe A. Peixoto ◽  
Laurent Pouységu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document